50

DAFTAR PUSTAKA

American Heart Association, 2007. Task Force on Practive Guidelines. J Am Coll

Cardiol. Available at : http://content.onlinejacc.org/cgi/content/full/50/7/e1.

[Accessed Desember 13th 2017]

Armin, A.Z., Nakano, M., Virmani, R., Fuster, V., 2012. Acute Coronary Events.

Circulation, 1147-56.

Berezin, A.E., Lisovaya, O.A., 2014. Predictive Value of Circulating Vascular

Endothelial Growth Factor-1 Level Measured Repeatedly During Long-Term

Follow-Up in Patients with Arterial Hypertension after Acute Ischemic Stroke.

Angiology: Open Access: 2: 119-216.

Brown, C.T., 2005. Penyakit aterosklerostik koroner. In: Hartanto H, Susi N,

Wulansari P, Mahanani DA, penyunting. Patofisiologi - Konsep Klinis Proses-

Proses Penyakit (6th ed). Jakarta: EGC, 576-612.

Carmeliet, P., Jain, R.K., 2011. Molecular mechanisms and clinical applications of

angiogenesis. Nature, 473: 298-307.

Departemen Kesehatan Republik Indonesia, 2006. Pharmaceutical Care untuk

Pasien Penyakit Jantung Koroner: Fokus Sindrom Koroner Akut, 1st ed.

Jakarta: Bakti Husada.

Departemen Kesehatan RI, 2014. Riset Kesehatan Dasar 2013. Available from:

http://depkes.go.id/downloads/riskesdas2013/Hasil%20Riskesdas%202013.p

df. [Accessed January 8th 2018].

 51

European heart journal, 2015. Task force for the management of acute coronary

syndromes in patients presenting without persistent ST-Segment Elevation of

the European Society of Cardiology (ESC). Available from:

http://eurheartj.oxfordjournals.org [Accessed January 20th, 2018]

Ferarra, N., Smyth, T., 1997. The Biology of Vascular Endothelial Growth Factor.

Endocrine Review, 4-21.

Furqan, A., Faktor Yang Dapat Dimodifikasi Dan Tidak Dapat Dimodifikasi Pada

Penderita Sindroma Koroner Akut Di RSUP. H. Adam Malik Medan, e-USU

Repository Universitas Sumatera Utara, 2013: 10-15.

Hermann, D.M., Zechariah, A., 2009. Implications of vascular endothelial growth

factor for postischemic neurovascular remodeling. J Cereb Blood Flow Metab;

29: 1620-1643.

Herminingsih, S., Uddin, I., Tanuwidjojo, S., 2007. Patogenesis Penyakit

Kardiovaskuler Pada Diabetes Melitus. Dalam: Darmono, Suhartono, T.,

Pemayun, TGD., Sumanto, F., editor. Naskah Lengkap Diabetes Melitus

Ditinjau dari berbagai aspek penyakit dalam.Semarang: BP.Undip, 245-56.

Hicklin, D.J., Ellis, L.M., 2005. Role of the vascular endothelial growth factor

pathway in tumor Growth adn Angiogenesis. Jorunal of Clinical Oncology,

Vol.23, No.5, 1-12.

Hoeben, A., Landuyt, B., Highley M.S., et al., 2004. Vascular Endothelial Growth

Factor and Angiogenesis. Pharmacological Reviews, 549-580.

Immanuel, S., 2011. High Density Lipoprotein Sebagai Faktor Protektif atau Faktor

Risiko Penyakit Kardiovaskuler. Dalam: Oesman, F., Timan, I.S., editor.

 52

Pendidikan Berkesinambungan Patologi Klinik 2011. Jakarta: Departemen

Patologi Klinik Fakultas Kedokteran Universitas Indonesia, 42-64.

Jain, K., Suryakumar, G., Prasad, R., Ganju, L., 2014. Upregulation of

cytoprotective defense mechanisms and hypoxia-responsive proteins imparts

tolerance to acute hypobaric hypoxia. High Alt Med Biol: 14: 65-77.

Jelkmann, W., 2001. Pitfalls in the measurement of circulating vascular endothelial

growth factor. Clin Chemist, 617-23.

Jokso, J., et al., 2000. Vascular endothelial growth factor (VEGF) and its effect on

Angiogenesis. Med Sci Monit, 1047-52.

Kementerian Kesehatan RI, 2014. Situasi Kesehatan Jantung. Jakarta: Pusat Data

dan Informasi Kementerian Kesehatan RI, 1-8.

Khurana, D., Mathur, D., Prabhakar, S., Thakur, K., Anand, A., 2013. Vascular

endothelial growth factor and monocyte chemoattractant protein-1 levels

unaltered in symptomatic atherosclerotic carotid plaque patients from north

India. Front Neurol: 4: 27.

Kim, S., Jun, J.H., Kim, J., Kim do, W., Jang, Y.H., Lee, W.J., 2013. HIF-1 and

VEGF expression correlates with thrombus remodeling in cases of

intravascular papillary endothelial hyperplasia. Int J Clin Exp Pathol: 6; 2912-

2918.

Konopka, A., Janas, J., Piotrowski, W., et al., 2013. Concentration of Vascular

Endothelial Growth Factor in Patient with Acute Coronary Syndrome. Italy:

Cytokine, 664-669.
 53

Kranz, A., Rau, C., Kochs, M., Waltenberger, J., 2000. Elevation of Vascular

Endothelial Growth Factor-A Serum Levels Following Acute Myocardial

Infarction. J Mol Cell Cardiol, 65–72.

Kumar, A., Cannon, P., 2009. Acute Coronary Syndromes: Diagnosis and

Management, Part I. Mayo Clin Proc, 917-93.

Kut, C., Gabhann, F.M., Popel, A.S., 2007. Where is VEGF in the body? A meta

analysis of VEGF distribution in cancer. Br J Cancer, 978-85.

Lacchini, R., Luizon, M.R., Gasparini, S., Ferreira-Sae, M.C., Schreiber, R.,

Nadruz, W., et al., 2014. Effect of genetic polymorphisms of vascular

endothelial growth factor on left ventricular hypertrophy in patients with

systemic hypertension. Am J Cardiol; 113: 491-496.

Lamon,B.E., Hajjar, D.P., 2008. Inflammation at the molecular interface if

atherogenesis: an arthropological journey.Am.J. Pathol.173, 1253-1264.

Matsudaira, K., Maeda, K., Okumura, N., Yoshikawa, D., Morita, Y., Mitsuhashi,

H., et al, 2012. On behalf of the Nagoya Acute Myocardial Infarction Study

(NAMIS) Group. Impact of low levels of vascular endothelial growth factor

after myocardial infarction on 6-month clinical outcome: Results from the

Nagoya Acute Myocardial Infarction Study. Jepang: Circ J, 1509 – 1516.

Moreno, P.R., Purushothaman, K.R., Sirol, M., Levy, A.P., Fuster, V., 2006.

Neovascularization in human atherosclerosis. Circulation: 113: 2245- 2252.

Neufeld, G., Cohen, T., Gengrinovitch, S., Poltorak, Z., 1999. Vascular endothelial

growth factor (VEGF) and its receptors. FASEB J, 9-22.

 54

Niu, J., Han, X., Yin J., et al., 2016. Correlation between vascular endothelial

growth factor and long-term prognosis in patients with acute myocardial

infarction. Jepang: Experimental and Therapeutic Medicine, 475-479.

Ortega, N., Hutchings, H., Plouet, J., 1999. Signal relays in the VEGF

system. Front Biosci, 141-152.

Perhimpunan Dokter Spesialis Kardiovaskular Indonesia, 2015. Pedoman

Tatalaksana Pencegahan Penyakit Kardiovaskular Pada Perempuan. Diunduh

dari : http://www.inaheart.org/upload/file/Women_Guideline-Fix(5).pdf

[Accessed March 8th 2018]

Plank, M.J., Sleeman, B.D., 2003. Tumor-induced Angiogenesis: A Review,

Journal of Theoretical Medicine, 137-53.

Poltorak, Z., Cohen, T., Sivan, R., et al., 1997. VEGF145, a secreted vascular

endothelial growth factor isoform that binds to extracellular matrix. J Biol

Chem, 7151-7158.

Rosen, L.S., 2002. Clinical Experience with Angiogenesis Signaling Inhibitors :

Focus on Vascular Endothelial Growth Factor (VEGF) Blockers. Cancer

Control, 36-44.

Shimokawahara, H., Jougasaki, M., Setoguchi, M., et al., 2014. Relationship

between vascular endothelial growth factor and leftventricular dimension in

patients with acute myocardial infarction. J Cardiol.

Shibuya, M., 2006. Differential Roles of Vascular Endothelial Factor Receptor-1

and Receptor-2 in Angiogenesis. Journal of Biochemistry and Molecular

Biology, Vol.39, No.5, 469-78.

 55

Suarez, C., Fjallman, A., Hofer, K., 2006. The role of VEGF receptor in

angiogenesis; complex partnerships. Cell Mol Life Sci, 63:601-15.

Suryaatmaja, M., 2010. Peran Penanda Biokimia Jantung Pada Pasien PJK. Jakarta:

Bagian Interna FKUI, 178-89.

Tabernero, T., 2007. The Role of VEGF and EGFR Inhibitor : Implication for

Combining anti-VEGF adn Anti EGFR Agents. Mol Cancer Res; 5(3), 203-16.

Tada, Y., Ogawa, M., Watanabe, R., Zempo, H., Takamura, C., Suzuki, J., et al.,

2014. Neovascularization induced by hypoxia inducible transcription factor is

associated with the improvement of cardiac dysfunction in experimental

autoimmune myocarditis. Expert Opin Investig Drugs: 23; 149-162.

Takahashi, H., Shibuya, M., 2005. The Vascular Endothelial Growth Factor

(VEGF) and VEGF receptor system and its role under physiological and

pathological condition. Clin Sci, 227-41.

Testa, U., Pannitteri, G., Condorelli, G.L., 2008. Vascular endothelial growth

factors in cardiovascular medicine. J Cardiovasc Med (Hagerstown); 9: 1190-

1221.

Tschirch, E., Weber, B., Kohne, P., Guthmann, F., Gise, A., 2009. Vascular

endothelial growth factor as a marker for tissue hypoxia and transfusion need

in anemic infants : a prospective clinical study. Pediatrics, 784-90.

Valentin, F., Wayne, A., Obert, A., 2014. Cardiac Catheterization, Cardiac

Angiography and Coronary Blood Flow and pressure Measurements. In Hurts

The Heart. 17th ed.483-537.

 56

WHO, 2013. About Cardiovascular diseases. Available from URL :

http://www.who.int/cardiovascular_diseases/about_cvd/en/. [Cited March,

18th 2018.].

Ziello, J., Jovin, I., Huang, Y., 2007. Hipoxic inducible factor (HIF-1) regulatory

pathway and its potential for therapeutic intervention in malignancy and

ischemia. Yale: J Biol Med, 51-60.